DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients' airway epithelial cells.
Summary
Using enzymatic methylome profiling and single-cell RNA-seq of nasal epithelium, the study identified 3,112 differentially methylated regions in COVID-19, with hypermethylation of ciliary genes that remained transcriptionally repressed in ciliated cells up to 12 months post-infection. An independent cohort validated symptom-dependent repression, implicating acute epigenetic changes in long-term airway dysfunction.
Key Findings
- Identified 3,112 differentially methylated regions in nasal epithelial cells of COVID-19 patients versus controls.
- Ciliary function genes were hypermethylated and remained transcriptionally repressed in ciliated cells up to 12 months post-infection.
- An independent 6-month post-infection cohort validated symptom-dependent repression of ciliary genes.
Clinical Implications
Highlights mucociliary dysfunction as a target for monitoring and potential intervention in post-COVID care; motivates exploration of epigenetic-modifying or ciliary-supporting therapies.
Why It Matters
Provides mechanistic, cell-type–resolved evidence linking acute epigenetic alterations to prolonged ciliary dysfunction, a plausible driver of post-acute COVID-19 respiratory symptoms.
Limitations
- Modest sample sizes limit generalizability and causal inference
- Nasal epithelium may not fully represent lower airway biology; functional rescue experiments were not reported
Future Directions
Test reversibility of ciliary gene repression with epigenetic modulators, extend to lower airway samples, and correlate with longitudinal clinical phenotypes of post-COVID respiratory symptoms.
Study Information
- Study Type
- Cohort
- Research Domain
- Pathophysiology
- Evidence Level
- II - Prospective observational multi-omics analysis with longitudinal follow-up and external validation
- Study Design
- OTHER